

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.83692236 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.74112308 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.56442350 |
| 4 | glutamate secretion (GO:0014047) | 5.45684285 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.18428122 |
| 6 | vocalization behavior (GO:0071625) | 5.17196697 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.03873500 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.93153242 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.86053537 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.82664813 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.81922847 |
| 12 | protein localization to synapse (GO:0035418) | 4.70012392 |
| 13 | neurotransmitter secretion (GO:0007269) | 4.69658436 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.65881423 |
| 15 | proline transport (GO:0015824) | 4.64101085 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.59136402 |
| 17 | establishment of mitochondrion localization (GO:0051654) | 4.58739450 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.58424014 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.53614850 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.47470290 |
| 21 | locomotory exploration behavior (GO:0035641) | 4.26177052 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.19405369 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.16425661 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.13200478 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.05698650 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 3.97566530 |
| 27 | neurotransmitter transport (GO:0006836) | 3.94752655 |
| 28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.93549567 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.92365109 |
| 30 | nucleobase catabolic process (GO:0046113) | 3.86310398 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.84172139 |
| 32 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84075506 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.68277002 |
| 34 | exploration behavior (GO:0035640) | 3.63249137 |
| 35 | response to histamine (GO:0034776) | 3.63219979 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60702379 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.58667526 |
| 38 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.57600411 |
| 39 | synaptic vesicle endocytosis (GO:0048488) | 3.56454900 |
| 40 | long-term synaptic potentiation (GO:0060291) | 3.53566641 |
| 41 | regulation of neurotransmitter levels (GO:0001505) | 3.52729353 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 3.51690217 |
| 43 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.51588058 |
| 44 | mitochondrion transport along microtubule (GO:0047497) | 3.51588058 |
| 45 | glycosphingolipid biosynthetic process (GO:0006688) | 3.49132788 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.47822578 |
| 47 | behavioral fear response (GO:0001662) | 3.44931042 |
| 48 | behavioral defense response (GO:0002209) | 3.44931042 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.43620906 |
| 50 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.39892790 |
| 51 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.39892790 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.39892644 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39608445 |
| 54 | neuromuscular process controlling posture (GO:0050884) | 3.38766950 |
| 55 | transferrin transport (GO:0033572) | 3.37706114 |
| 56 | auditory behavior (GO:0031223) | 3.37691687 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.37597577 |
| 58 | striatum development (GO:0021756) | 3.37132108 |
| 59 | long-term memory (GO:0007616) | 3.34453497 |
| 60 | regulation of synapse structural plasticity (GO:0051823) | 3.32459296 |
| 61 | regulation of postsynaptic membrane potential (GO:0060078) | 3.31353348 |
| 62 | organelle transport along microtubule (GO:0072384) | 3.30919879 |
| 63 | positive regulation of membrane potential (GO:0045838) | 3.29731049 |
| 64 | neurofilament cytoskeleton organization (GO:0060052) | 3.29654051 |
| 65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.29122318 |
| 66 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.28808284 |
| 67 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24250132 |
| 68 | fear response (GO:0042596) | 3.23299453 |
| 69 | axonal fasciculation (GO:0007413) | 3.23129448 |
| 70 | presynaptic membrane organization (GO:0097090) | 3.22711493 |
| 71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.22035707 |
| 72 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.20321363 |
| 73 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20189382 |
| 74 | regulation of synaptic plasticity (GO:0048167) | 3.18122691 |
| 75 | behavioral response to cocaine (GO:0048148) | 3.16078365 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.15116260 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.13996395 |
| 78 | regulation of synapse maturation (GO:0090128) | 3.12549016 |
| 79 | ferric iron transport (GO:0015682) | 3.12398433 |
| 80 | trivalent inorganic cation transport (GO:0072512) | 3.12398433 |
| 81 | synaptic transmission (GO:0007268) | 3.10787670 |
| 82 | cellular potassium ion homeostasis (GO:0030007) | 3.10519798 |
| 83 | positive regulation of vesicle fusion (GO:0031340) | 3.09704540 |
| 84 | activation of protein kinase A activity (GO:0034199) | 3.08275957 |
| 85 | neuronal ion channel clustering (GO:0045161) | 3.08009383 |
| 86 | neuron recognition (GO:0008038) | 3.06937949 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06168752 |
| 88 | daunorubicin metabolic process (GO:0044597) | 3.05063379 |
| 89 | polyketide metabolic process (GO:0030638) | 3.05063379 |
| 90 | doxorubicin metabolic process (GO:0044598) | 3.05063379 |
| 91 | vesicle transport along microtubule (GO:0047496) | 3.05000812 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 3.04247470 |
| 93 | sodium ion export (GO:0071436) | 3.04122930 |
| 94 | regulation of vesicle fusion (GO:0031338) | 3.02755847 |
| 95 | startle response (GO:0001964) | 3.02614965 |
| 96 | innervation (GO:0060384) | 3.02408703 |
| 97 | positive regulation of synaptic transmission (GO:0050806) | 3.01643611 |
| 98 | synaptic vesicle transport (GO:0048489) | 3.01408435 |
| 99 | establishment of synaptic vesicle localization (GO:0097480) | 3.01408435 |
| 100 | protein localization to cilium (GO:0061512) | 2.99776044 |
| 101 | establishment of vesicle localization (GO:0051650) | 2.99508256 |
| 102 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.98840448 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97700862 |
| 104 | signal release (GO:0023061) | 2.95867665 |
| 105 | membrane hyperpolarization (GO:0060081) | 2.94810704 |
| 106 | membrane depolarization during action potential (GO:0086010) | 2.94444396 |
| 107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.93829861 |
| 108 | dendritic spine morphogenesis (GO:0060997) | 2.92101152 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90655119 |
| 110 | regulation of glutamate secretion (GO:0014048) | 2.89565958 |
| 111 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.88042637 |
| 112 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.87013648 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.86929798 |
| 114 | membrane depolarization (GO:0051899) | 2.86731698 |
| 115 | regulation of synaptic transmission (GO:0050804) | 2.86161857 |
| 116 | cell migration in hindbrain (GO:0021535) | 2.85610256 |
| 117 | learning (GO:0007612) | 2.84521929 |
| 118 | negative regulation of dendrite development (GO:2000171) | 2.84412870 |
| 119 | synapse assembly (GO:0007416) | 2.82271629 |
| 120 | layer formation in cerebral cortex (GO:0021819) | 2.82197628 |
| 121 | detection of calcium ion (GO:0005513) | 2.81854036 |
| 122 | dendritic spine organization (GO:0097061) | 2.80167054 |
| 123 | vesicle docking involved in exocytosis (GO:0006904) | 2.77159415 |
| 124 | regulation of dendritic spine development (GO:0060998) | 2.76860173 |
| 125 | response to auditory stimulus (GO:0010996) | 2.74640434 |
| 126 | adult walking behavior (GO:0007628) | 2.70543173 |
| 127 | positive regulation of mitochondrial fission (GO:0090141) | 2.69841870 |
| 128 | mechanosensory behavior (GO:0007638) | 2.69636792 |
| 129 | neuromuscular synaptic transmission (GO:0007274) | 2.67131061 |
| 130 | neurotransmitter uptake (GO:0001504) | 2.66964223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.65354571 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.08540166 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.11001418 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.02512281 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.88709614 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79712409 |
| 7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.63531234 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58237656 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53710138 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.43569846 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39329691 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39329691 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35108659 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33532880 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27351523 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24208171 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23207232 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19597995 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18277688 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15426254 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11489988 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.10402309 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.09669462 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04240824 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90134956 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89528673 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85987383 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85923397 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83455997 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80461953 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75374009 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73944141 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73616990 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71994646 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.70350869 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66648619 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65375499 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61204094 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60652958 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53377116 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.53366625 |
| 42 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.53279264 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48690197 |
| 44 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.42708857 |
| 45 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.42708857 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.42708857 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42693286 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.40490664 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38462631 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38422887 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.37399075 |
| 52 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35053455 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33257195 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30843148 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30620959 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29381342 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28881351 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27981884 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27084778 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25818002 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25818002 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.23874143 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23737523 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23661098 |
| 65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23440299 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22477325 |
| 67 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.21920888 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21266956 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20276471 |
| 70 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.19880894 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18842466 |
| 72 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17611543 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16791386 |
| 74 | AR_19668381_ChIP-Seq_PC3_Human | 1.16512636 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16017427 |
| 76 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15002007 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13838344 |
| 78 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13636594 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12788776 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12424529 |
| 81 | JUN_21703547_ChIP-Seq_K562_Human | 1.11398304 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11110965 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10915190 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10525690 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09672578 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09508756 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09155943 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07569535 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05736246 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05639668 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05243154 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05149553 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04042400 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03043485 |
| 95 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02913690 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02331513 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02200366 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02090948 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01778520 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01636477 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01427025 |
| 102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01265170 |
| 103 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99557096 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98745131 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98745131 |
| 106 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98666689 |
| 107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98508892 |
| 108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98412896 |
| 109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97101025 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95330537 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95057599 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94888477 |
| 113 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.94612773 |
| 114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93832605 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93339438 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92652654 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92588717 |
| 118 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92427745 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90924470 |
| 120 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.90892934 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88118483 |
| 122 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.85523077 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84562687 |
| 124 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84347340 |
| 125 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84095495 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83779575 |
| 127 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83595351 |
| 128 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.83528251 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82771230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.14903040 |
| 2 | MP0003880_abnormal_central_pattern | 4.55843489 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.71620700 |
| 4 | MP0004270_analgesia | 3.45360675 |
| 5 | MP0009046_muscle_twitch | 3.37587211 |
| 6 | MP0009745_abnormal_behavioral_response | 3.14354831 |
| 7 | MP0002064_seizures | 3.13631581 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.09598171 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.06679910 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.85084557 |
| 11 | MP0003122_maternal_imprinting | 2.79228319 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.70058260 |
| 13 | MP0002736_abnormal_nociception_after | 2.59809420 |
| 14 | MP0004858_abnormal_nervous_system | 2.53800420 |
| 15 | MP0002272_abnormal_nervous_system | 2.53672508 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.53275286 |
| 17 | MP0002822_catalepsy | 2.46764843 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.33609789 |
| 19 | MP0001486_abnormal_startle_reflex | 2.31444683 |
| 20 | MP0003787_abnormal_imprinting | 2.22635158 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.22385779 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.15401458 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.13115182 |
| 24 | MP0001970_abnormal_pain_threshold | 2.03284375 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.99311434 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.99081230 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.95864632 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.88854222 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.85767437 |
| 30 | MP0002184_abnormal_innervation | 1.83017423 |
| 31 | MP0005499_abnormal_olfactory_system | 1.78170705 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.78170705 |
| 33 | MP0001984_abnormal_olfaction | 1.74982689 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.70649009 |
| 35 | MP0001529_abnormal_vocalization | 1.63629959 |
| 36 | MP0004924_abnormal_behavior | 1.62189988 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.62189988 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.61720769 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.56804169 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.52625708 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.52488679 |
| 42 | MP0000955_abnormal_spinal_cord | 1.48104492 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.46978238 |
| 44 | MP0000778_abnormal_nervous_system | 1.46176092 |
| 45 | MP0004142_abnormal_muscle_tone | 1.45499793 |
| 46 | MP0003879_abnormal_hair_cell | 1.44552375 |
| 47 | MP0003121_genomic_imprinting | 1.40723214 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.39487009 |
| 49 | MP0008569_lethality_at_weaning | 1.31550042 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.30836912 |
| 51 | MP0002102_abnormal_ear_morphology | 1.30384396 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.29874559 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.28660914 |
| 54 | MP0001905_abnormal_dopamine_level | 1.27845171 |
| 55 | MP0001188_hyperpigmentation | 1.25786925 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.24566935 |
| 57 | MP0003123_paternal_imprinting | 1.23651272 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.20504158 |
| 59 | MP0004043_abnormal_pH_regulation | 1.17558209 |
| 60 | MP0003690_abnormal_glial_cell | 1.17475110 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.14924846 |
| 62 | MP0008872_abnormal_physiological_respon | 1.12747537 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.12297872 |
| 64 | MP0004742_abnormal_vestibular_system | 1.11635322 |
| 65 | MP0003329_amyloid_beta_deposits | 1.09368844 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.06350959 |
| 67 | MP0002229_neurodegeneration | 1.06231891 |
| 68 | MP0003011_delayed_dark_adaptation | 1.05762832 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.04868387 |
| 70 | MP0003633_abnormal_nervous_system | 1.04445401 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 1.02818025 |
| 72 | MP0002090_abnormal_vision | 1.00578426 |
| 73 | MP0000920_abnormal_myelination | 0.98594682 |
| 74 | MP0000604_amyloidosis | 0.96546119 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.93449954 |
| 76 | MP0002152_abnormal_brain_morphology | 0.92141603 |
| 77 | MP0004085_abnormal_heartbeat | 0.91956027 |
| 78 | MP0002069_abnormal_eating/drinking_beha | 0.91382707 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.91379673 |
| 80 | MP0001177_atelectasis | 0.90038829 |
| 81 | MP0005187_abnormal_penis_morphology | 0.89414680 |
| 82 | MP0002752_abnormal_somatic_nervous | 0.87792941 |
| 83 | MP0000013_abnormal_adipose_tissue | 0.86659370 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.85702533 |
| 85 | MP0003631_nervous_system_phenotype | 0.84610576 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.82865148 |
| 87 | MP0003283_abnormal_digestive_organ | 0.82500457 |
| 88 | MP0004885_abnormal_endolymph | 0.81957127 |
| 89 | MP0008995_early_reproductive_senescence | 0.81786186 |
| 90 | MP0008874_decreased_physiological_sensi | 0.81713351 |
| 91 | MP0004147_increased_porphyrin_level | 0.81212881 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.79217219 |
| 93 | MP0005253_abnormal_eye_physiology | 0.78004279 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76001651 |
| 95 | MP0005535_abnormal_body_temperature | 0.74398860 |
| 96 | MP0004233_abnormal_muscle_weight | 0.73474175 |
| 97 | MP0002751_abnormal_autonomic_nervous | 0.72396129 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.68914346 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.67465308 |
| 100 | MP0003634_abnormal_glial_cell | 0.66541477 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.65623434 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.65513806 |
| 103 | MP0008260_abnormal_autophagy | 0.65436783 |
| 104 | MP0001664_abnormal_digestion | 0.62526945 |
| 105 | MP0003632_abnormal_nervous_system | 0.62058528 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 0.60943126 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.56878263 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.56726466 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.56555640 |
| 110 | MP0000751_myopathy | 0.55763658 |
| 111 | MP0003195_calcinosis | 0.54822867 |
| 112 | MP0003724_increased_susceptibility_to | 0.54445500 |
| 113 | MP0004484_altered_response_of | 0.53277977 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.52547180 |
| 115 | MP0003172_abnormal_lysosome_physiology | 0.51487546 |
| 116 | MP0003956_abnormal_body_size | 0.51131785 |
| 117 | MP0001943_abnormal_respiration | 0.51110792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.12943853 |
| 2 | Atonic seizures (HP:0010819) | 5.62427408 |
| 3 | Febrile seizures (HP:0002373) | 5.51786863 |
| 4 | Myokymia (HP:0002411) | 5.27035295 |
| 5 | Focal seizures (HP:0007359) | 5.25062375 |
| 6 | Hyperventilation (HP:0002883) | 4.91328501 |
| 7 | * Epileptic encephalopathy (HP:0200134) | 4.86821309 |
| 8 | Absence seizures (HP:0002121) | 4.59253793 |
| 9 | Dialeptic seizures (HP:0011146) | 4.50655175 |
| 10 | Visual hallucinations (HP:0002367) | 4.37870467 |
| 11 | Abnormality of the lower motor neuron (HP:0002366) | 4.37261685 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.99070938 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.89822688 |
| 14 | Amblyopia (HP:0000646) | 3.50019543 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.48389987 |
| 16 | Urinary urgency (HP:0000012) | 3.04356624 |
| 17 | Peripheral hypomyelination (HP:0007182) | 2.98760626 |
| 18 | Failure to thrive in infancy (HP:0001531) | 2.93075600 |
| 19 | Pheochromocytoma (HP:0002666) | 2.87071803 |
| 20 | Bilateral microphthalmos (HP:0007633) | 2.86880454 |
| 21 | Hepatoblastoma (HP:0002884) | 2.82792650 |
| 22 | Gait imbalance (HP:0002141) | 2.79469339 |
| 23 | Status epilepticus (HP:0002133) | 2.73483517 |
| 24 | Excessive salivation (HP:0003781) | 2.66153681 |
| 25 | Drooling (HP:0002307) | 2.66153681 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.64948878 |
| 27 | Lower limb muscle weakness (HP:0007340) | 2.62892948 |
| 28 | Papilledema (HP:0001085) | 2.62746694 |
| 29 | Resting tremor (HP:0002322) | 2.62364804 |
| 30 | Clonus (HP:0002169) | 2.61359268 |
| 31 | Depression (HP:0000716) | 2.61115325 |
| 32 | Horizontal nystagmus (HP:0000666) | 2.60504339 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.58119548 |
| 34 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.57975375 |
| 35 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.57975375 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 2.57581584 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.57394416 |
| 38 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.56738758 |
| 39 | Spastic tetraplegia (HP:0002510) | 2.56495613 |
| 40 | Neuroendocrine neoplasm (HP:0100634) | 2.55689628 |
| 41 | Broad-based gait (HP:0002136) | 2.54819117 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.54028552 |
| 43 | Intention tremor (HP:0002080) | 2.53573577 |
| 44 | Truncal ataxia (HP:0002078) | 2.53093423 |
| 45 | Hemiparesis (HP:0001269) | 2.52703940 |
| 46 | Congenital primary aphakia (HP:0007707) | 2.49038278 |
| 47 | Torticollis (HP:0000473) | 2.48835483 |
| 48 | Action tremor (HP:0002345) | 2.48771255 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.48723907 |
| 50 | Poor eye contact (HP:0000817) | 2.47665031 |
| 51 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46697314 |
| 52 | CNS hypomyelination (HP:0003429) | 2.45217805 |
| 53 | Inability to walk (HP:0002540) | 2.38817913 |
| 54 | Generalized myoclonic seizures (HP:0002123) | 2.37280983 |
| 55 | Apathy (HP:0000741) | 2.36771992 |
| 56 | Polyphagia (HP:0002591) | 2.35934569 |
| 57 | Impaired social interactions (HP:0000735) | 2.33733773 |
| 58 | Abnormal social behavior (HP:0012433) | 2.33733773 |
| 59 | Nephrogenic diabetes insipidus (HP:0009806) | 2.33431865 |
| 60 | Impaired pain sensation (HP:0007328) | 2.32052661 |
| 61 | Abnormality of pain sensation (HP:0010832) | 2.32052661 |
| 62 | Tetraplegia (HP:0002445) | 2.31581116 |
| 63 | Abnormal hair whorl (HP:0010721) | 2.29708893 |
| 64 | Generalized hypotonia (HP:0001290) | 2.29533273 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.27998628 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.27782664 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 2.26278333 |
| 68 | Abnormality of the labia minora (HP:0012880) | 2.24294568 |
| 69 | Diminished motivation (HP:0000745) | 2.23811815 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.21672917 |
| 71 | Anxiety (HP:0000739) | 2.20370907 |
| 72 | Focal dystonia (HP:0004373) | 2.18504817 |
| 73 | Specific learning disability (HP:0001328) | 2.18403971 |
| 74 | Absent speech (HP:0001344) | 2.18052005 |
| 75 | Bradykinesia (HP:0002067) | 2.16967777 |
| 76 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.16605240 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.15860560 |
| 78 | * Muscular hypotonia of the trunk (HP:0008936) | 2.14587954 |
| 79 | Ankle clonus (HP:0011448) | 2.13822977 |
| 80 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13326688 |
| 81 | Akinesia (HP:0002304) | 2.11889492 |
| 82 | Limb dystonia (HP:0002451) | 2.11047438 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 2.10663961 |
| 84 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.09260218 |
| 85 | Upper limb muscle weakness (HP:0003484) | 2.07248158 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.03609155 |
| 87 | Diplopia (HP:0000651) | 2.03609155 |
| 88 | Lissencephaly (HP:0001339) | 2.02591869 |
| 89 | Paraplegia (HP:0010550) | 2.02473323 |
| 90 | Dysmetria (HP:0001310) | 2.01622933 |
| 91 | Poor suck (HP:0002033) | 2.00782570 |
| 92 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.00638811 |
| 93 | Dyskinesia (HP:0100660) | 2.00226005 |
| 94 | Hypoplasia of the corpus callosum (HP:0002079) | 1.99980394 |
| 95 | Hypoplasia of the fovea (HP:0007750) | 1.99057557 |
| 96 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.99057557 |
| 97 | Impaired vibratory sensation (HP:0002495) | 1.97718537 |
| 98 | Neurofibrillary tangles (HP:0002185) | 1.96557037 |
| 99 | Sleep apnea (HP:0010535) | 1.95799187 |
| 100 | Poor coordination (HP:0002370) | 1.94451210 |
| 101 | Ulnar claw (HP:0001178) | 1.94078234 |
| 102 | Craniofacial dystonia (HP:0012179) | 1.92450563 |
| 103 | Impaired smooth pursuit (HP:0007772) | 1.92113754 |
| 104 | Oligodactyly (hands) (HP:0001180) | 1.92063568 |
| 105 | Split foot (HP:0001839) | 1.92032205 |
| 106 | Protruding tongue (HP:0010808) | 1.91443556 |
| 107 | Oligomenorrhea (HP:0000876) | 1.90268773 |
| 108 | Postural instability (HP:0002172) | 1.90262100 |
| 109 | Retinal dysplasia (HP:0007973) | 1.89943594 |
| 110 | Mutism (HP:0002300) | 1.89559239 |
| 111 | Sensory axonal neuropathy (HP:0003390) | 1.87168710 |
| 112 | Ragged-red muscle fibers (HP:0003200) | 1.86325240 |
| 113 | Fetal akinesia sequence (HP:0001989) | 1.86297055 |
| 114 | Hand muscle atrophy (HP:0009130) | 1.85544468 |
| 115 | Abnormality of glycolysis (HP:0004366) | 1.85519954 |
| 116 | Increased serum pyruvate (HP:0003542) | 1.85519954 |
| 117 | Dysmetric saccades (HP:0000641) | 1.85394596 |
| 118 | Papillary thyroid carcinoma (HP:0002895) | 1.83638700 |
| 119 | Progressive inability to walk (HP:0002505) | 1.83473185 |
| 120 | Cortical visual impairment (HP:0100704) | 1.81809462 |
| 121 | Spastic gait (HP:0002064) | 1.81777920 |
| 122 | Spastic paraplegia (HP:0001258) | 1.79955368 |
| 123 | Spastic tetraparesis (HP:0001285) | 1.79837635 |
| 124 | Progressive microcephaly (HP:0000253) | 1.79722178 |
| 125 | Scanning speech (HP:0002168) | 1.79619043 |
| 126 | Gait ataxia (HP:0002066) | 1.79460045 |
| 127 | Broad foot (HP:0001769) | 1.78149195 |
| 128 | Neoplasm of the heart (HP:0100544) | 1.77544253 |
| 129 | Primitive neuroectodermal tumor (HP:0030065) | 1.76718184 |
| 130 | Neuroblastic tumors (HP:0004376) | 1.76718184 |
| 131 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.76718184 |
| 132 | Neuroblastoma (HP:0003006) | 1.76718184 |
| 133 | Genital tract atresia (HP:0001827) | 1.76561611 |
| 134 | Central scotoma (HP:0000603) | 1.76440544 |
| 135 | Delusions (HP:0000746) | 1.76116885 |
| 136 | Vaginal atresia (HP:0000148) | 1.75960032 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75271161 |
| 138 | Agitation (HP:0000713) | 1.74559704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.10898434 |
| 2 | GRK5 | 3.69234095 |
| 3 | CASK | 3.60855617 |
| 4 | MAP3K9 | 3.22364234 |
| 5 | MAP3K4 | 3.17619430 |
| 6 | EPHA4 | 3.10458734 |
| 7 | TRIM28 | 3.06957265 |
| 8 | MAP2K7 | 2.86404476 |
| 9 | MAP2K4 | 2.63871939 |
| 10 | MAP3K12 | 2.60938939 |
| 11 | MINK1 | 2.45422751 |
| 12 | MARK1 | 2.43657228 |
| 13 | AKT3 | 2.27774220 |
| 14 | ERBB3 | 2.08062358 |
| 15 | DAPK2 | 1.96163077 |
| 16 | PLK2 | 1.89042906 |
| 17 | NTRK1 | 1.77366032 |
| 18 | GRK7 | 1.73266669 |
| 19 | PRPF4B | 1.69138901 |
| 20 | ADRBK2 | 1.68430370 |
| 21 | DAPK1 | 1.66794476 |
| 22 | PAK6 | 1.62101915 |
| 23 | NTRK2 | 1.61617408 |
| 24 | CDK19 | 1.59894768 |
| 25 | EPHA3 | 1.59115721 |
| 26 | ARAF | 1.56781693 |
| 27 | MAP4K2 | 1.54823050 |
| 28 | CSNK1G2 | 1.53283436 |
| 29 | KSR2 | 1.44334571 |
| 30 | CDK12 | 1.39950517 |
| 31 | PRKCG | 1.38522743 |
| 32 | CSNK1G3 | 1.38510994 |
| 33 | RIPK4 | 1.28206107 |
| 34 | GRK6 | 1.27359425 |
| 35 | CSNK1A1L | 1.25624160 |
| 36 | KSR1 | 1.21055916 |
| 37 | CAMKK2 | 1.21028317 |
| 38 | CAMKK1 | 1.19991649 |
| 39 | CDK5 | 1.18826353 |
| 40 | NME1 | 1.18194876 |
| 41 | CSNK1G1 | 1.12880103 |
| 42 | SIK3 | 1.11943111 |
| 43 | CCNB1 | 1.10174919 |
| 44 | NEK1 | 1.09607146 |
| 45 | TYRO3 | 1.08241631 |
| 46 | TSSK6 | 1.08065771 |
| 47 | MAPK13 | 1.07643111 |
| 48 | DYRK2 | 1.02150423 |
| 49 | MAPK7 | 1.00742937 |
| 50 | WNK1 | 0.98126642 |
| 51 | GRK1 | 0.96223660 |
| 52 | STK38 | 0.94231442 |
| 53 | LATS2 | 0.94124231 |
| 54 | PDK4 | 0.93715885 |
| 55 | PDK3 | 0.93715885 |
| 56 | SGK2 | 0.91576292 |
| 57 | ADRBK1 | 0.89949602 |
| 58 | SGK494 | 0.88814424 |
| 59 | SGK223 | 0.88814424 |
| 60 | MAP3K2 | 0.86735638 |
| 61 | CDK18 | 0.86672272 |
| 62 | CAMK2A | 0.85553756 |
| 63 | CDK14 | 0.83146802 |
| 64 | CAMK4 | 0.81649424 |
| 65 | DYRK1A | 0.80979653 |
| 66 | MOS | 0.80287047 |
| 67 | CDK15 | 0.79873109 |
| 68 | BRAF | 0.76191785 |
| 69 | OXSR1 | 0.72617599 |
| 70 | PDK2 | 0.69827356 |
| 71 | WNK3 | 0.69529387 |
| 72 | SIK2 | 0.68112997 |
| 73 | BMPR2 | 0.67450823 |
| 74 | CDK11A | 0.66623463 |
| 75 | FRK | 0.65493760 |
| 76 | INSRR | 0.65404664 |
| 77 | MATK | 0.64970852 |
| 78 | PNCK | 0.64198440 |
| 79 | MAP3K5 | 0.62926156 |
| 80 | UHMK1 | 0.61824563 |
| 81 | PRKCZ | 0.61372870 |
| 82 | LIMK1 | 0.60241471 |
| 83 | CAMK2B | 0.60061607 |
| 84 | PRKD3 | 0.58726730 |
| 85 | FES | 0.58327594 |
| 86 | PAK3 | 0.57317971 |
| 87 | PKN1 | 0.56576729 |
| 88 | TESK1 | 0.56221504 |
| 89 | CAMK1 | 0.56117744 |
| 90 | SGK3 | 0.54431394 |
| 91 | BCKDK | 0.53792109 |
| 92 | TAOK3 | 0.53590227 |
| 93 | PINK1 | 0.51254229 |
| 94 | NEK6 | 0.51182986 |
| 95 | PHKG2 | 0.50653459 |
| 96 | PHKG1 | 0.50653459 |
| 97 | PRKCE | 0.49802158 |
| 98 | TNK2 | 0.49604325 |
| 99 | MARK2 | 0.49178043 |
| 100 | MAPK12 | 0.47952523 |
| 101 | DYRK1B | 0.46286172 |
| 102 | MAP3K13 | 0.45512839 |
| 103 | PTK2B | 0.45265558 |
| 104 | MAP2K1 | 0.44895569 |
| 105 | BCR | 0.43007438 |
| 106 | PRKCH | 0.42191045 |
| 107 | RAF1 | 0.42056007 |
| 108 | RET | 0.40451143 |
| 109 | RPS6KA3 | 0.39944665 |
| 110 | SGK1 | 0.39846868 |
| 111 | PRKAA1 | 0.39831465 |
| 112 | PDK1 | 0.39760321 |
| 113 | STK11 | 0.39301228 |
| 114 | CAMK2G | 0.39042949 |
| 115 | LMTK2 | 0.38769137 |
| 116 | ALK | 0.38722611 |
| 117 | FER | 0.38571203 |
| 118 | MAPK10 | 0.37613898 |
| 119 | PRKACA | 0.36723490 |
| 120 | IRAK2 | 0.36718199 |
| 121 | MAP2K6 | 0.36683075 |
| 122 | CAMK2D | 0.34587792 |
| 123 | PRKACB | 0.33921749 |
| 124 | MAP3K1 | 0.33157425 |
| 125 | BRSK1 | 0.33142153 |
| 126 | CSNK1D | 0.32849021 |
| 127 | JAK2 | 0.31700974 |
| 128 | SRPK1 | 0.28708839 |
| 129 | PRKG1 | 0.28624645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.22444622 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.18463183 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.99485206 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.88717902 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75114293 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.56076323 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.46279477 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.44958391 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.44651645 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35255152 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23213844 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22174383 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.15185503 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.11895600 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07618577 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.98905155 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.89271883 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80181798 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.79150570 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.73011817 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54127917 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.53525111 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46776538 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44396762 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37834566 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37758958 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36434214 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31203016 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.30927213 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30115085 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28264968 |
| 32 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25143590 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24321402 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.23498750 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22427480 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22306138 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20030812 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17861411 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16635947 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15601243 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13728086 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10943120 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.07208394 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.03251851 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98895646 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98428802 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98342646 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97083798 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95625408 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93936013 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85372551 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84864303 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84724548 |
| 54 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77969770 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77649006 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76376568 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76357334 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74814462 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73065009 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72987162 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72152587 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69194113 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69014934 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68257131 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.68164808 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67460039 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65566787 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65233121 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.64946401 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64885658 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60071649 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.57103670 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56721788 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54187979 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52258185 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50571713 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49633407 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49254805 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49151329 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48453208 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48165357 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48127838 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47111876 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46695923 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46361770 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45051308 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.44670447 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42247849 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42100596 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40795286 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40193710 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37823158 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37027022 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35829838 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35686514 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.35511658 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34506505 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33776500 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33485358 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33417588 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32640982 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31908072 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.31269910 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.30932230 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30926473 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.30610440 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28354575 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26922295 |
| 109 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26877671 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.25493167 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24416600 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22925801 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22502988 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20211632 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.20204840 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.20002011 |
| 117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.17994177 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17992494 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17978239 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.17765411 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.17661759 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17360046 |

